Cite Filings / APUS / 0001213900-25-045604

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Apimeds Pharmaceuticals US, Inc. Filed 2025-05-19 Acc 0001213900-25-045604

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-05-20 4 Options or other derivatives
2025-05-20 4 Options or other derivatives
2025-05-20 4 Options or other derivatives
2025-05-20 4 Options or other derivatives
2025-05-20 4 Chairman and CMO acquired 250,000 shares (grant or award)
2025-05-20 4 Chief Executive Officer acquired 750,000 shares (grant or award)
2025-05-19 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…